Microglia are important participants in inflammatory responses in the central nervous system. We previously observed that tumor necrosis factor alpha (TNFα) induces the expression of the formylpeptide receptor mFPR2 on microglial cells. This chemoattractant receptor mediates microglial cell chemotaxis in response to a variety of peptides, including amyloid β peptide (Aβ 42 ), a major pathogenic factor in Alzheimer's disease (AD). In search for agents that regulate microglial activation, we unexpectedly found that IL-10 enhanced the expression of mFPR2 on TNFα-activated microglia. This was associated with a markedly increased microglial chemotaxis to Aβ 42 and its endocytosis via mFPR2. Mechanistic studies revealed that the synergistic effect of IL-10 on TNFα-induction of mFPR2 in microglia was dependent on activation of p38 MAPK. Our results suggest that IL-10 may affect the pathogenic process of AD by up-regulating mFPR2 and thus favoring the recognition and internalization of Aβ 42 by activated microglial cells.
Introduction
Microglial cells in the central nervous system (CNS) share characteristics of tissue macrophages (Flaris et al., 1993) . Under normal conditions microglial cells are in a resting state, but they become rapidly activated upon contact with pro-inflammatory signals and participate in CNS responses to infection, inflammation, injury and neurodegeneration (Gonzalez-Scarano and MartinGarcia, 2005) . Microglial cells express a number of chemoattractant receptors, migrate in response to selected chemoattractants and accumulate in inflammatory brain lesions where chemoattractants are elevated (Sorensen et al., 1999; Iribarren et al., 2005c) . Proinflammatory stimuli also induce selected chemoattractant receptors in microglial cells presumably to expand the scope of cell responses in pathological conditions. For instance, mouse microglial cells activated by agonists for Toll-like receptors (TLR) or tumor necrosis factor (TNF) α, show increased expression of a G protein-coupled formylpeptide receptor mFPR2 (Chen et al., 2006; Cui et al., 2002b,c; Iribarren et al., 2005a) , which is a homologue of human FPRL1. Both, mFPR2 and FPRL1 recognize a diverse array of chemotactic agonists including the bacterial formylated peptide fMLF, HIV-1 envelope protein-derived peptides (Le et al., 2001b) , as well as the 42 amino acid form of Aβ peptide (Aβ 42 ), a key pathogenic agent associated with the CNS lesions of Alzheimer's disease (AD) (Le et al., 2001a; Tiffany et al., 2001 ). Activation of mFPR2 or FPRL1 elicits a cascade of signals in phagocytic leukocytes and microglia resulting in increased cell chemotaxis, phagocytosis and release of pro-inflammatory mediators (Le et al., 2001b (Le et al., , 2002 . Therefore, mFPR2 or FPRL1 may play an important role in host defense and inflammatory responses.
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